Side-by-side financials for ALLO and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALLO | BNTX |
|---|---|---|
| Market cap | - | $22.90 B |
| US-listed rank | - | #572 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$190.89M | - |
| SEC filings | 558 | 548 |
Full pages: Allogene Therapeutics, Inc. and BioNTech SE, or browse the full rankings.